Kimaritec is developing new therapies for cancer, by manipulating the body’s protein recycling pathway to drive protein degradation of critical oncoproteins. Cancer remains a disease with high unmet medical need, with many patients succumbing to tumours which become unresponsive to current therapy. ...See more
Headquarters:
Australia
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2020 (5 years)
Address:
TRANSLATIONAL RESEARCH INSTITUTE; 37 KENT STREET; BRISBANE, QLD 4102, AU
LOW
spending power
